• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The wet patient: understanding patients with overactive bladder and incontinence.

作者信息

Serels Scott

机构信息

Bladder Control Center of Norwalk, CT 06850, USA.

出版信息

Curr Med Res Opin. 2004 Jun;20(6):791-801. doi: 10.1185/030079904125003593.

DOI:10.1185/030079904125003593
PMID:15200735
Abstract

Overactive bladder (OAB) is a constellation of lower urinary tract symptoms, including urinary frequency and urgency,which can occur with or without urinary incontinence. Incontinence is present in over half of female patients with OAB. This condition affects more than 33 million Americans and imposes considerable economic, social, and psychological burdens. Although continued improvements in the pharmacologic management of lower urinary tract disorders have led to the availability of well-tolerated, characteristic features, prevalence and epidemiology, effective treatment options, the symptoms of OAB are generally underreported by patients and under treated by healthcare professionals. Heightened awareness of the multifaceted disease burden imposed by OAB and increased understanding of the characteristics of patients who are likely to be most severely affected, in particular those who suffer from incontinence, may improve the timely identification, diagnosis, and clinical management of the syndrome, enhancing both the health and quality of life of these patients. This review will summarize the clinical consequences, and management of OAB, with particular focus on the incontinent patient.

摘要

相似文献

1
The wet patient: understanding patients with overactive bladder and incontinence.
Curr Med Res Opin. 2004 Jun;20(6):791-801. doi: 10.1185/030079904125003593.
2
Defining overactive bladder: epidemiology and burden of disease.膀胱过度活动症的定义:流行病学与疾病负担
Urology. 2004 Dec;64(6 Suppl 1):2-6. doi: 10.1016/j.urology.2004.10.047.
3
Lower urinary tract symptoms in women.女性下尿路症状
Curr Opin Urol. 2009 Jul;19(4):337-41. doi: 10.1097/MOU.0b013e32832b659d.
4
Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.索利那新用于治疗伴有尿失禁的膀胱过度活动症:症状困扰及与健康相关的生活质量结果
Ann Pharmacother. 2007 Mar;41(3):391-8. doi: 10.1345/aph.1H581. Epub 2007 Mar 6.
5
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).索利那新治疗膀胱过度活动症后的症状困扰及健康相关生活质量结局:卫喜康开放标签试验(VOLT)
Clin Ther. 2006 Nov;28(11):1935-46. doi: 10.1016/j.clinthera.2006.11.010.
6
Overactive bladder significantly affects quality of life.膀胱过度活动症严重影响生活质量。
Am J Manag Care. 2000 Jul;6(11 Suppl):S580-90.
7
Understanding the elements of overactive bladder: questions raised by the EPIC study.了解膀胱过度活动症的要素:EPIC研究提出的问题
BJU Int. 2008 Jun;101(11):1381-7. doi: 10.1111/j.1464-410X.2008.07573.x. Epub 2008 Mar 10.
8
The causes and consequences of overactive bladder.膀胱过度活动症的病因及后果。
J Womens Health (Larchmt). 2006 Apr;15(3):251-60. doi: 10.1089/jwh.2006.15.251.
9
A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.一项基于人群的关于女性尿失禁、膀胱过度活动症及其他下尿路症状的纵向调查。
Eur Urol. 2009 Apr;55(4):783-91. doi: 10.1016/j.eururo.2009.01.007. Epub 2009 Jan 13.
10
The economic impact of overactive bladder syndrome in six Western countries.六个西方国家膀胱过度活动症的经济影响。
BJU Int. 2009 Jan;103(2):202-9. doi: 10.1111/j.1464-410X.2008.08036.x.

引用本文的文献

1
Alterations of the myovesical plexus of the human overactive detrusor.人逼尿肌过度活跃时膀胱肌丛的改变。
Biomed Res Int. 2014;2014:754596. doi: 10.1155/2014/754596. Epub 2014 Apr 15.
2
Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder.琥珀酸索利那新10毫克每日一次的疗效与安全性:一项针对膀胱过度活动症患者的多中心、III期、随机、双盲、安慰剂对照平行组试验。
Curr Ther Res Clin Exp. 2009 Dec;70(6):405-20. doi: 10.1016/j.curtheres.2009.11.001.
3
Social, economic, and health utility considerations in the treatment of overactive bladder.
膀胱过度活动症治疗中的社会、经济和健康效用考量
Open Access J Urol. 2010 Feb 11;2:11-24. doi: 10.2147/rru.s4166.
4
Rehabilitation vs drug therapy for urge urinary incontinence: short-term outcome.急迫性尿失禁的康复治疗与药物治疗:短期疗效
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Apr;18(4):407-11. doi: 10.1007/s00192-006-0163-1. Epub 2006 Jul 11.